Events

On the 29th of January 2019, Ian Friedland, Sumathi Nambiar, Mair Powell, and David Shlaes will join us for a live webinar about antibacterial drug enhancer combinations and non-traditional products. Following their short presentations, the speakers will be available on the line to respond to your questions.

The meeting is being organised as part of a programme of work to strengthen the research links between the UK and India with the specific aim of jointly addressing the challenge of AMR.  

Speakers include Ann Eakin, Senior Scientific Officer Office of Biodefense, Research Resources & Translational Research, DMID/NIAID/NIH, member of the CARB-X Joint Oversight Committee. In this presentation, Ann Eakin (US National Institute of Allergy and Infectious Diseases, NIAID) will provide an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development […]

Workshop hosted by the Centre for Cellular And Molecular Platforms (C-CAMP), a member of the CARB-X Accelerator Network.

Speakers include Kevin Outterson, CARB-X Executive Director. The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.  

Global views, local problems: Innovative solutions to AMR and infection challenges. The British Society for Antimicrobial Chemotherapy (BSAC) 2019 Spring Conference offers a state of the art overview of the infection management and antimicrobial resistance landscape. The programme includes keynote lectures, plenary and parallel sessions, debates and an opening series of spotlight presentations – offering […]

Speakers include Kevin Outterson, CARB-X Executive Director. The Longitude Prize is an international challenge prize competition that will ultimately select one point-of-care diagnostic product to receive a grand payout of 8 million British Pounds ($9.1 million). The winner will have proven that their test can significantly reduce misuse or overuse of antibiotics by creating an […]

Speakers include Karen Gallant, CARB-X Global Project Director. The 1st Bacteriophage Therapy Summit is the only meeting uniting large pharma, biotech companies, research institutions and technology experts to harness bacteriophage science and accelerate the clinical development of effective phage therapy. Join the leaders in phage therapy product development as they discuss the latest data-driven case […]

Speakers include Kevin Outterson, CARB-X Executive Director. Join 120+ health policy leaders, academics and other experts across the industry for a frank discussion to catalyse progress in bringing AMR under control, before it is too late. A series of expert panel discussions will dig into the topics that matter the most, using the convening power […]

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this third webinar, we will discuss the development of antibacterial drug enhancer combinations and non-traditional products. The webinar will be held from 5:00 pm – 6:30 […]